Ticker brief

PRAX PRAXIS PRECISION MEDICINES I

Consumer, Non-cyclical · Biotechnology

last close
$318.52
1 day
-0.3%
14 days
+12.8%
mkt cap
$8.9B
signals 14d
10
authors 14d
5
Sentiment — last 14 days
daily mean sentiment, 2026-06-22 → 2026-06-30 · now -0.30 (−1 bearish … +1 bullish)
Who spoke5
authorgradetrader scoresignalsmean sent
@Biotech2k1A-0.035+0.36
@OzmosiHealthC·2+0.33
@BioStocksC-0.391+0.55
@CrweWorldC·1+0.15
@FierceBiotechA-0.091-0.30
Recent signals10of 10 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-06-30@FierceBiotech-0.30Praxis faces FDA decision delay, a negative regulatory timing event.-4.9%
2026-06-29@CrweWorld+0.15Company announces extension period for relutrigine treatment program.-9.1%
2026-06-29@Biotech2k1+0.25Watchlist of value levels across sectors, no explicit buy action.-9.1%
2026-06-29@OzmosiHealth+0.15Praxis announces extension period for Relutrigine treatment programs.-9.1%
2026-06-28@Biotech2k1+0.25States he always holds through data and cites PRAX as an example that went well.-2.8%
2026-06-26@Biotech2k1+0.45Lists core portfolio names by category and plans 70% cash before bubble pops, capped to six.-2.8%
2026-06-25@Biotech2k1+0.45Lists selected top holdings from deep dives, capped to first six tickers.-2.8%
2026-06-22@Biotech2k1+0.40Author says PRAX now has three breakthrough therapy designations.+5.0%
2026-06-22@OzmosiHealth+0.50Praxis received FDA Breakthrough Therapy Designation for Elsunersen.+5.0%
2026-06-22@BioStocks+0.55PRAX receives FDA Breakthrough Therapy Designation for Elsunersen.+5.0%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.